CorMedix Inc. CRMD 深 沪
等待开盘 01-29 09:30:00 美东时间
7.75
0.000
0.00%
华盛通- 最 高7.92
- 今 开7.77
- 成交量 190.91万股
- 最 低 7.71
- 昨 收 7.75
- 总市值 6.05亿
- 52周最高 17.43
- 市盈率 静 --
- 换手率 2.45%
- 52周最低 5.60
- 委 比 96.97%
- 总股本 7805.87万
- 历史最高 52.00
- 量 比 0.70
- 振 幅 2.71%
- 历史最低 0.73
- 每 手 1
- 风险率 1.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
Guardant Health, Jabil, NeoGenomics, Darden, Cormedix Insider Moves
Insiders have been trading these 5 stocks: (($GH)), (($JBL)), (($NEO)), (($DRI)...
01-24 21:00
U.S. RESEARCH ROUNDUP-Applied Materials, Procter & Gamble, RLI
U.S. RESEARCH ROUNDUP-Applied Materials, Procter & Gamble, RLI Jan 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Procter & Gamble and RLI, on Friday. HIGHLIGHTS * Applied Materials Inc AMAT.O : Be
01-23 15:13
CorMedix Inc. Director Janet Dillione Reports Disposal of Common Shares
CorMedix Inc. Director Janet Dillione Reports Disposal of Common Shares Janet Dillione, Director of CorMedix Inc., reported a disposal of common shares of CorMedix Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using
01-23 10:30
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
Where Cormedix Stands With Analysts
Cormedix (NASDAQ:CRMD) has been analyzed by 7 analysts in the last three months...
01-22 06:00
RBC Capital Maintains Outperform on Cormedix, Lowers Price Target to $13
RBC Capital analyst Leonid Timashev maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $22 to $13.
01-21 22:38
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX Jan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, KLA and WEX, on Wednesday. HIGHLIGHTS * IBM IBM.N : JP Morgan raises target price to $312 from $290 * KLA Corp KLAC.O : Deut
01-21 16:26
CorMedix shares are trading lower. The company announced preliminary Q4 and FY25 revenue results.
CorMedix shares are trading lower. The company announced preliminary Q4 and FY2...
01-08 22:04
Cormedix Sees FY2026 Sales $300.000M-$320.000M.
Cormedix (NASDAQ:CRMD) sees FY2026 sales of $300.000 million-$320.000 million.
01-08 21:41
